Opzelura – Atopic Dermatitis – Dec Display Banners HCP Wallboard Extension – 23170

In 2019, five patients advocate organizations collaborated with the FDA to conduct an external, patient-focused drug development meeting on atopic dermatitis (AD) called More Than Skin Deep, according to Wendy Smith Begolka,...

Adult patients with AD are receptive to, and can benefit from, a digitally delivered, targeted treatment intervention, according to a study in Dermatology and Therapy. Jonathan I. Silverberg, MD, and colleagues assessed the...

For adults with moderate-to severe AD, depressive symptoms are common, according to a study published in Acta Dermato -Venereologica. Lina U. Ivert, MD, and colleagues conducted a prospective, real-world, clinical cohort study...

It is not always easy for people to accept their medical state, which can lead to denial. When this happens, managing that patient grows more challenging. As a result, according to medical writer Naveed Saleh, MD, MS, patients...

The severity of children’s AD in first grade may predict its persistence in sixth grade, according to a study published in the Journal of Dermatology. Akio Tanaka, MD, PhD, and colleagues examined primary school children during...